Tasas

24 rows found, displaying 1 to 20.[First/Prev] 1, 2 [Next/Last]
Tipo Descripción Euros
1.01 Fee for the evaluation, authorisation and registration of a new medicine for human use (application in accordance with article 17, with the exception of the provision in 17.3) 20529.17
1.02 Fee for the evaluation, authorisation and registration of a new generic medicine for human use (application in accordance with article 17.3) 8350.71
1.03 Fee for the evaluation, authorisation and registration of a new medicinal gas 8350.71
1.04 Fee for changing the ownership of a marketing authorisation for a medicine for human use, or for changing the owner's representative. 697.57
1.05 Fee for the variation of a marketing authorisation for medicines for human use, classified as of «major importance» Type II 7051.73
1.06 Fee for the variation of a marketing authorisation for medicines for human use, classified as Type IB 1236.85
1.07 Fee for the variation of a marketing authorisation for medicines for human use, classified as type IA (including those of type IA with immediate notification) 717.25
1.08 Fee for the renewal application for a medicine for human use 2319.51
1.09 Annual fee for the maintenance of an already-authorised medicine for human use 370.0
1.10 Fee for the authorisation procedure for a parallel imported medicine for human use 896.49
1.11 Fee for the variation for a parallel imported medicine for human use 362.86
1.12 Fee for the renewal for a parallel imported medicine for human use 362.86
1.13 Fee for the notification of an imported medicine for human use 355.49
1.14 Fee for issuing an European certification for the batch release of vaccines and blood products for human use when the batch-analysis of a medicine is required 1200.0
1.15a Fee for the batch release of blood products and vaccines in accordance with articles 41.4 and 43.3 of Royal Decree 1345/2007, of 11th October: (a) each individual application 100.0
1.15b Fee for the batch release of blood products and vaccines in accordance with articles 41.4 and 43.3 of Royal Decree 1345/2007, of 11th October: (b) between 6 and 10 applications/year (per year) 500.0
1.15c Fee for the batch release of blood products and vaccines in accordance with articles 41.4 and 43.3 of Royal Decree 1345/2007, of 11th October: (c) between 11 and 40 applications/year (per year) 1500.0
1.15d Fee for the batch release of blood products and vaccines in accordance with articles 41.4 and 43.3 of Royal Decree 1345/2007, of 11th October: (d) between 41 and 160 applications/year (per year) 3500.0
1.15e Fee for the batch release of blood products and vaccines in accordance with articles 41.4 and 43.3 of Royal Decree 1345/2007, of 11th October: (e) for more than 160 applications/year (per year) 5000.0
1.16 Fee for issuing an European certification for the batch release of vaccines and blood products for human use when a bulk-analysis is required (by bulk) 336.0

Si desea localizar información relacionada con el contenido de esta página, utilice el buscador

© Agencia Española de Medicamentos y Productos Sanitarios